The effect of vildagliptin versus metformin on hepatic steatosis in type 2 diabetic patients: a randomized controlled trial

Authors

Institutions

Publication Details

Journal
BMC Pharmacology and Toxicology
Published
2024-12-13
DOI
https://doi.org/10.1186/s40360-024-00818-7
Citations
1
Primary Topic
Liver Disease Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.39

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The effect of vildagliptin versus metformin on hepatic steatosis in type 2 diabetic patients: a randomized controlled trial

Hosam M. Ahmad, Fatma Kamel, Asmaa S. Mohamed, Mohammed A. Sharawy
1 citations
BMC Pharmacology and Toxicology
Liver Disease Diagnosis and Treatment
0.39
article

The effect of vildagliptin versus metformin on hepatic steatosis in type 2 diabetic patients: a randomized controlled trial

Hosam M. Ahmad, Fatma Kamel, Asmaa S. Mohamed, Mohammed A. Sharawy
article en
1 citations

Abstract

No abstract available for this paper.
BMC Pharmacology and ToxicologyVol. 25(1)
Ministry of Health and Population (EG), Port Said University (EG), Minia University (EG)
Science and Technology Development Fund
Good health and well-being
Openalex Percentile: Top 31%
Liver Disease Diagnosis and Treatment
0.39
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.